Aptevo Therapeutics Inc (APVO) — Financial Flexibility Index
Aptevo Therapeutics Inc (APVO) has a Financial Flexibility Index of -0.96x as of March 2026. Free cash flow of $-7.96 Million (operating CF $-7.96 Million minus capex $0.00) represents -1% of total liabilities ($8.29 Million). Check total reinvestment intensity of Aptevo Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aptevo Therapeutics Inc Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Aptevo Therapeutics Inc across 12 annual periods. For the full cash flow conversion analysis, see APVO cash flow conversion.
Annual Financial Flexibility Index for Aptevo Therapeutics Inc (2014–2025)
Year-by-year free cash flow to debt coverage for Aptevo Therapeutics Inc. Explore APVO cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.61x | $-25.59 Million | $-25.59 Million | $9.81 Million | ▼ -18.8% |
| 2024 | -2.19x | $-23.79 Million | $-23.79 Million | $10.84 Million | ▼ -136.2% |
| 2023 | -0.93x | $-11.73 Million | $-11.73 Million | $12.62 Million | ▲ +28.1% |
| 2022 | -1.29x | $-20.99 Million | $-21.02 Million | $16.24 Million | ▼ -241.5% |
| 2021 | -0.38x | $-20.97 Million | $-21.68 Million | $55.38 Million | ▲ +52.1% |
| 2020 | -0.79x | $-29.23 Million | $-29.32 Million | $36.95 Million | ▲ +22.1% |
| 2019 | -1.02x | $-42.23 Million | $-42.38 Million | $41.57 Million | ▲ +25.3% |
| 2018 | -1.36x | $-50.45 Million | $-51.42 Million | $37.09 Million | ▼ -18.4% |
| 2017 | -1.15x | $-40.17 Million | $-41.57 Million | $34.97 Million | ▼ -38.1% |
| 2016 | -0.83x | $-34.35 Million | $-36.86 Million | $41.29 Million | ▲ +58.0% |
| 2015 | -1.98x | $-47.23 Million | $-48.76 Million | $23.84 Million | ▼ -9.2% |
| 2014 | -1.81x | $-46.02 Million | $-47.01 Million | $25.36 Million | — |